Senate Bill 499 aims to amend the definition of hemp within Wisconsin's Controlled Substances Act. The bill redefines hemp as the plant Cannabis sativa L. and its derivatives, with a total tetrahydrocannabinol (THC) concentration, including tetrahydrocannabinolic acid, of not more than 0.3 percent on a dry weight basis. It also introduces the term "industrial hemp," which encompasses various uses of the plant, such as for stalk, seeds, and edible products. The bill clarifies that hemp does not include certain products, such as viable cannabis seeds exceeding the THC threshold or hemp-derived cannabinoid products that contain synthesized cannabinoids or quantifiable amounts of THC.

Additionally, the bill includes several amendments to existing statutes to align with the new definition of hemp. Notably, it renumbers and amends section 94.55 (1) to change "Definition" to "Definitions" and specifies that hemp does not include prescription drug products approved by the FDA. Other amendments involve the removal of the term "delta-9-tetrahydrocannabinol" in favor of "tetrahydrocannabinol" in various sections, ensuring consistency in terminology. Overall, the bill seeks to clarify and expand the legal framework surrounding hemp and its derivatives in Wisconsin.

Statutes affected:
Bill Text: 94.55(2)(b)2m.b, 94.55, 94.55(2)(b)4s, 94.55(3m)(a)2, 94.67(15c), 94.67, 446.01(2)(a), 446.01, 450.03(1)(k), 450.03, 450.07(1m), 450.07, 961.01(14), 961.01, 961.14(4)(t)3, 961.14, 961.32(2m)(b), 961.32, 961.32(3)(a)2